SuperworthOcular Therapeutix market cap OCUL
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $1.4B
- Highest close in our data
- $3.1B
- Dec 2025
Ocular Therapeutix is worth $1.4B at the close on Oct 23, 2026, at $6.50 a share.
That is down 29% over the last year and up 181% over five years.
Its highest close in our data was $3.1B in Dec 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.4B | $1.4B | $2.5B | −47% |
| 2025 | $2.7B | $1B | $3.1B | +102% |
| 2024 | $1.3B | $305.8M | $1.8B | +275% |
| 2023 | $354.2M | $167.2M | $576M | +64% |
| 2022 | $216.4M | $201M | $493.4M | −59% |
| 2021 | $534M | $471.9M | $1.6B | −64% |
| 2020 | $1.5B | $209.1M | $1.6B | +634% |
| 2019 | $201.5M | $113.1M | $221.5M | +19% |
| 2018 | $169.7M | $143.4M | $304.6M | +30% |
| 2017 | $131M | $118.3M | $325.1M | −37% |
| 2016 | $208.2M | $108.2M | $352.7M | −10% |
| 2015 | $231.8M | $177.5M | $915.8M | −53% |
| 2014 | $490.8M | $286.5M | $490.8M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Ocular Therapeutix's size, closest first, today.
| Company | Market cap |
|---|---|
| OCULOcular Therapeutix | $1.4B |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| PAHCPhibro Animal Health | $1.6B |
| ANIPANI Pharmaceuticals | $1.7B |
| OMEROmeros | $1.2B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| HRMYHarmony Biosciences | $2.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| ABUSArbutus Biopharma | $831M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Ocular Therapeutix
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.